Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients

Introduction: Gefitinib is a selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) widely used in lung adenocarcinoma (LUAD) patients harboring sensitive EGFR mutations. Although it has a good initial efficacy, acquired resistance to gefitinib is eventually inevitable. Stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Junyong, Lan, Huiyin, Li, Wei, Xie, Shuanshuan, Tong, Zhongkai, Song, Xiaolian, Wang, Changhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
LncRNAs and CircRNAs: Biomarkers of Therapeutic Resistance and Tumor Progression
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772949/
https://www.ncbi.nlm.nih.gov/pubmed/36537128
http://dx.doi.org/10.1177/15330338221139167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772949/
https://www.ncbi.nlm.nih.gov/pubmed/36537128
http://dx.doi.org/10.1177/15330338221139167

Ejemplares similares